Page last updated: 2024-09-05

sb 203580 and pyrithione

sb 203580 has been researched along with pyrithione in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(pyrithione)
Trials
(pyrithione)
Recent Studies (post-2010) (pyrithione)
3,48941,137163340

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)pyrithione (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.05
large T antigenBetapolyomavirus macacae30.26

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araragi, S; Higashimoto, M; Kondoh, M; Sato, M; Takiguchi, M; Tasaki, E; Watanabe, Y1

Other Studies

1 other study(ies) available for sb 203580 and pyrithione

ArticleYear
Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells.
    European journal of biochemistry, 2002, Volume: 269, Issue:24

    Topics: Apoptosis; Blotting, Western; Caspases; Cell Death; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Imidazoles; In Situ Nick-End Labeling; Ionophores; Leukemia; Mitogen-Activated Protein Kinases; Necrosis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Thiones; Time Factors; Zinc

2002